New Economy Portfolio Update..Looking to buy a stock with a solid catalyst on Oct 1st which is closing in on the next 60 days.
Alert..bought starter in PBMD in New Economy Portfolio at $3.00 for their catalyst on Oct 1st. Shares are a challenge to grab. Increased volume will allow for closer & more reasonable ask/bids on level 2 as the company definitely has the shares O/S to allow for solid trading liquidity. Underfollowed company.
Market Cap is 109M. 30m in cash with zero debt. 32m in float & 35m O/S. Avg 3m volume is 10K. Avg 10 day volume is 15K. 52wk low is $1.70 and 52wk high is $6.96.
PBMD- Prima Biomed Feb 2013 Presentation: http://bit.ly/155mFzu From thewallstreetanalyzer.com: CEO Interview http://bit.ly/17Qq835 2:50 of interview is catalyst discussion!
CAN-003 abstract accepted for oral presentation at the European Cancer Congress in Amsterdam. Dr. Jeffrey Goh, the lead author, will deliver an oral presentation of top-line results from the CAN-003 trial during the Gynecological Cancer session that starts at 9:00am, Central European Time, on October 1, 2013. CAN-003 is a 63-patient study of CVac for the maintenance treatment of epithelial ovarian cancer patients in remission. The CAN-003 results will be important to help inform the ongoing clinical development of CVac for ovarian cancer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.